Circulating microRNA-23b as a new biomarker for rheumatoid arthritis
نویسندگان
چکیده
منابع مشابه
Circulating microRNA-122 as a potential biomarker for liver injury.
Liver-specific microRNA-122 (miR-122) is involved in the replication of hepatitis C virus (HCV) and its potential as a target for antiviral intervention was recently assessed. However, the use of circulating miR-122 in the evaluation of liver function has never been reported. In the present study, changes of serum miRNA levels were first evaluated in acute human hepatotoxicity due to paraquat e...
متن کاملCirculating miR-23b as a Novel Biomarker for Early Risk Stratification After ST-Elevation Myocardial Infarction
BACKGROUND miR-23b overexpression can promote cardiomyocyte apoptosis and reduce cell growth under hypoxic conditions, suggesting that miR-23b acts as a biomarker for ST-elevation myocardial infarction (STEMI). The aim of this study was to investigate the effect of miR-23b on STEMI patients. MATERIAL AND METHODS We enrolled 80 eligible patients with STEMI and 60 control subjects. Blood samples ...
متن کاملEvaluation of Extracellular Circulating Human MicroRNA-197 as a Target Biomarker in Patients with Coronary Artery Disease
Background: Coronary Artery Disease (CAD) refers to the reduction or blockage of all or part of the coronary arteries due to the process of atherosclerosis or the presence of a clot. The aim of this study was to investigate the association of serum miR-197 as a diagnostic index in patients with coronary artery disease. Methods: In this study, 100 patients with CAD were selected. Extraction of...
متن کاملRole of microRNA as a biomarker in Alzheimer’s disease
Introduction: MicroRNAs are small, non-coding, and protected RNA molecules that regulate gene expression after transcription by mRNA degradation or inhibition of protein synthesis. The function of these molecules is critical to many cellular processes, including growth, development, differentiation, homeostasis, apoptosis, aging, stress resistance. In addition, some diseases including cancer, a...
متن کاملOsteoprotegerin as biomarker for persistence of rheumatoid arthritis
SIR, currently the treatment of RA is aimed at achieving low DAS remission. The ultimate aim, however, is to achieve DMARD-free sustained remission, which reflects the persistent absence of arthritis after cessation of treatment and is the closest proxy available for cure of RA. Although at present DMARD-free sustained remission can only be achieved in a minority of RA patients, recent data rev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gene
سال: 2019
ISSN: 0378-1119
DOI: 10.1016/j.gene.2019.06.001